Structural studies of human extracellular calcium-sensing receptor
人细胞外钙敏感受体的结构研究
基本信息
- 批准号:9293333
- 负责人:
- 金额:$ 31.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgonistAlzheimer&aposs DiseaseAmino AcidsBindingBinding SitesBiological ProcessBone DiseasesCalciumCalcium-Sensing ReceptorsCalmodulinCell ExtractsCell membraneCell surfaceCellsClinicalComplexCryoelectron MicroscopyCrystallizationCytoplasmic ReceptorsCytoplasmic TailDetergentsDimerizationDiseaseDisulfidesEquilibriumEventExhibitsExtracellular DomainFetal DevelopmentG-Protein-Coupled ReceptorsG-substrateGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGoalsHeterotrimeric GTP-Binding ProteinsHomeostasisHomodimerizationHomology ModelingHumanInositol PhosphatesInsectaIntracellular Signaling ProteinsIonsLeadLengthLifeLigand BindingLigandsMaintenanceMalignant NeoplasmsMammalian CellMapsMeasuresMetabolismMethodsMineralsMolecularMolecular ConformationMonitorMutationPTH genePhenylalaninePhysiologicalPlayProteinsReceptor ActivationReceptor GeneRegulationResearchRestRoleSignal PathwaySignal TransductionSignaling MoleculeSiteSpecificityStimulusStructural ModelsStructureSystemTherapeutic AgentsTransmembrane DomainX-Ray Crystallographybasecinacalcetdesigndetection of nutrientdimerextracellularinformation modelneuronal excitabilitynovel therapeuticspublic health relevancereceptorreceptor functionresponse
项目摘要
DESCRIPTION (provided by applicant): Human extracellular calcium-sensing receptor (CaSR) is a G-protein coupled receptor that maintains Ca2+ homeostasis through the regulation of parathyroid hormone secretion. CaSR also plays important roles in biological processes unrelated to Ca2+ balance such as fetal development. Abnormalities in the CaSR gene are associated with a vareity of Ca2+ homeostatic disorders including potentially life threatening hypercalcaemic conditions. Altered expression of CaSR has also been implicated in other diseases including cancer and Alzheimer's disease. Cinacalcet, an allosteric modulator of CaSR, is used clinically to treat disorders of bone and mineral metabolism. Therefore, elucidating the structure of CaSR may assist the design of valuable therapeutic agents. CaSR functions as a disulfide-tethered homodimer. It activates a diverse array of signaling pathways in a ligand-specific manner. In addition to its principal agonist, extracellular Ca2+, CaSR responds to a variety of agonists, and its activity is regulated by postive and negative allosteric modulators. The first part of this proposal is aimed at understanding the mechanisms by which CaSR recognizes structurally distinct ligands while maintaining binding affinity and specificity. We propose to solve the crystal structures of CaSR ectodomain bound to different agonists and allosteric modulators. The second aim is to identify the conformational changes associated with receptor activation based on the structures of CaSR ectodomain in the resting and active states. We plan to measure the functional effects of mutations that are designed based on these structures to probe the ligand binding sites and homodimer interface. The third part of the proposed research is to elucidate the signal transduction mechanism of CaSR by solving the structures of full-length receptor and its complexes with downstream signaling molecules. A combination of structural and functional analysis of CaSR will advance our understanding of the molecular basis of extracellular Ca2+ sensing and the general activation mechanisms of GPCR dimers.
描述(由申请人提供):人类额外的钙感应受体(CASR)是G蛋白夫妇,它保持Ca2+ tasr的作用在与Ca2+ Balance CH无关的生物过程中也无关紧要。 CA2+的体内疾病包括增强寿命的疾病,CASR的表达改变也是其他疾病,包括CASR的Cancludinger Alzheimer疾病。 GENTS的设计作为二硫键均匀二聚体。旨在理解CASSR在保持结合和特异性的同时,我们提出了与不同和同级群体结合的CASR结构的晶体结构。 G和活跃状态我们计划根据结构来衡量设计的功能效应,以探测配体结合位点和同型拟议研究的第三部分是通过求解CASR的信号转导机制,通过求解全长的结构受体和ITH的下游信号分子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QING R FAN其他文献
QING R FAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QING R FAN', 18)}}的其他基金
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10207012 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10582139 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10382430 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Molecular mechanism of dimeric G protein-coupled receptor signaling
二聚体G蛋白偶联受体信号传导的分子机制
- 批准号:
10588166 - 财政年份:2021
- 资助金额:
$ 31.6万 - 项目类别:
Mechanism of activation and modulation in human GABA(B) receptor
人 GABA(B) 受体的激活和调节机制
- 批准号:
9982345 - 财政年份:2018
- 资助金额:
$ 31.6万 - 项目类别:
Mechanism of activation and modulation in human GABA(B) receptor
人 GABA(B) 受体的激活和调节机制
- 批准号:
10224896 - 财政年份:2018
- 资助金额:
$ 31.6万 - 项目类别:
Mechanism of activation and modulation in human GABA(B) receptor
人 GABA(B) 受体的激活和调节机制
- 批准号:
10388693 - 财政年份:2018
- 资助金额:
$ 31.6万 - 项目类别:
Structural Studies of Metabotropic GABA Receptors
代谢型 GABA 受体的结构研究
- 批准号:
7915372 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Structural Studies of Metabotropic GABA Receptors
代谢型 GABA 受体的结构研究
- 批准号:
8118530 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
Structural Studies of Metabotropic GABA Receptors
代谢型 GABA 受体的结构研究
- 批准号:
8513349 - 财政年份:2009
- 资助金额:
$ 31.6万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 31.6万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别:
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes
开发类视黄醇途径的一流拮抗剂作为 2 型糖尿病的新型口服疗法
- 批准号:
10699637 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别:
Sigma 2 Receptor (TMEM97): Investigating the Peripheral Role of this Novel Therapeutic Target for Pain
Sigma 2 受体 (TMEM97):研究这种新型疼痛治疗靶点的外周作用
- 批准号:
10607436 - 财政年份:2023
- 资助金额:
$ 31.6万 - 项目类别: